Voluntary Public Acquisition Offer (Partial Offer) by Maruho Deutschland GmbH to the Shareholders of Biofrontera AG
Maruho Deutschland GmbH, Düsseldorf (business address in Leverkusen, Germany), has published the offer document for its tender offer (in the form of a partial offer) to the shareholders of Biofrontera AG to acquire up to a total of 4,322,530 of their registered no-par value shares in Biofrontera AG (ISIN DE0006046113 / WKN 604611) against a cash consideration of EUR 7.20 per Biofrontera-Share (updated offer as of May 27, 2019).
Documents published by Maruho Deutschland GmbH regarding the Offer are available on the internet at https://pharma-offer.de. Biofrontera AG accepts no responsibility for such contents or other information available on this website.
According to Art. 27 of the German Securities Acquisition and Takeover Act (WpÜG), the Management Board and the Supervisory Board of Biofrontera AG are required to give an opinion on the Offer and any changes of the Offer.
Below you will find the opinion of the Biofrontera AG Management Board and Supervisory Board and any updates thereto, as well as the opinion of our employees: